• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

    14.21 -0.22 (-1.52%)
    Streaming Delayed Price Updated: 11:10 AM EST, Feb 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 304,839
    Open 14.85
    Bid (Size) 14.15 (8,000)
    Ask (Size) 14.26 (100)
    Prev. Close 14.43
    Today's Range 14.19 - 14.90
    52wk Range 6.550 - 16.54
    Shares Outstanding 128,395,927
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    AUPH Stock Gains On Aurinia Pharma’s Q4 Beat, But 2026 Guidance Misses Estimates ↗
    Aurinia reported adjusted earnings per share of $1.53 on revenue of $77.1 million, while Wall Street analysts expected an adjusted EPS of $0.22 on revenue of $74.7 million, according to Koyfin data. 
    Via Stocktwits
    Aurinia Pharmaceuticals (NASDAQ:AUPH) Beats Q4 2025 Estimates and Provides 2026 Guidance ↗
    Via Chartmill

    Performance

    YTD
    -7.4%
    -7.4%
    1 Month
    -3.4%
    -3.4%
    3 Month
    -13.2%
    -13.2%
    6 Month
    +17.3%
    +17.3%
    1 Year
    +77.0%
    +77.0%

    More News

    Read More
    News headline image
    Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
    From Aurinia Pharmaceuticals Inc.
    Via Business Wire
    News headline image
    Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026
    From Aurinia Pharmaceuticals Inc.
    Via Business Wire
    News headline image
    Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? ↗
    Via The Motley Fool
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery ↗
    Via Stocktwits
    News headline image
    AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) Passes Louis Navellier's Strict Growth Stock Screen ↗
    Via Chartmill
    News headline image
    Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress
    From Aurinia Pharmaceuticals Inc.
    Via Business Wire
    News headline image
    A Peek at Aurinia Pharmaceuticals's Future Earnings ↗
    Via Benzinga
    News headline image
    FDA Drug Chief George Tidmarsh Resigns After Allegations Of Power Misuse ↗
    Via Benzinga
    News headline image
    Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025
    From Aurinia Pharmaceuticals Inc.
    Via Business Wire
    News headline image
    FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ ↗
    Via Stocktwits
    Topics Lawsuit
    News headline image
    Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Shows Strong Growth Traits in Fundamental Analysis ↗
    Via Chartmill
    News headline image
    Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025
    From Aurinia Pharmaceuticals Inc.
    Via Business Wire
    News headline image
    Aurinia Responds to Now Retracted LinkedIn Post
    From Aurinia Pharmaceuticals Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Passes Louis Navellier's Growth Screen ↗
    Via Chartmill
    News headline image
    United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results ↗
    Via Investor's Business Daily
    Topics ETFs
    News headline image
    Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Shows Strong Growth Metrics and Earnings Momentum ↗
    Via Chartmill
    News headline image
    Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded ↗
    Via Investor's Business Daily
    Topics ETFs
    News headline image
    Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Fits Louis Navellier’s High-Growth Stock Criteria ↗
    Via Chartmill
    News headline image
    Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter? ↗
    Via Investor's Business Daily
    News headline image
    Aurinia (AUPH) Q2 Revenue Jumps 22% ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025
    From Aurinia Pharmaceuticals Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Aurinia Pharmaceuticals Inc - Common Shares publicly traded?
    Yes, Aurinia Pharmaceuticals Inc - Common Shares is publicly traded.
    What exchange does Aurinia Pharmaceuticals Inc - Common Shares trade on?
    Aurinia Pharmaceuticals Inc - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Aurinia Pharmaceuticals Inc - Common Shares?
    The ticker symbol for Aurinia Pharmaceuticals Inc - Common Shares is AUPH on the Nasdaq Stock Market
    What is the current price of Aurinia Pharmaceuticals Inc - Common Shares?
    The current price of Aurinia Pharmaceuticals Inc - Common Shares is 14.21
    When was Aurinia Pharmaceuticals Inc - Common Shares last traded?
    The last trade of Aurinia Pharmaceuticals Inc - Common Shares was at 02/26/26 11:10 AM ET
    What is the market capitalization of Aurinia Pharmaceuticals Inc - Common Shares?
    The market capitalization of Aurinia Pharmaceuticals Inc - Common Shares is 1.82B
    How many shares of Aurinia Pharmaceuticals Inc - Common Shares are outstanding?
    Aurinia Pharmaceuticals Inc - Common Shares has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.